Stock Events

Health-Chem 

$0
4
+$0+0% Thursday 20:00

Statistics

Day High
0
Day Low
0
52W High
0
52W Low
0
Volume
260
Avg. Volume
0
Mkt Cap
1,233
P/E Ratio
0
Dividend Yield
-
Dividend
-

Earnings

30SepConfirmed
Q4 1997
Q1 1998
Q2 1998
-0.27
-0.18
-0.1
-0.02
Expected EPS
N/A
Actual EPS
-0.2697

People Also Follow

This list is based on the watchlists of people on Stock Events who follow HCLC. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap169.83B
Pfizer is a global pharmaceutical company that competes with Health-Chem in the development and marketing of medications and vaccines for a wide range of medical conditions.
Johnson & Johnson
JNJ
Mkt Cap372.29B
Johnson & Johnson offers a broad array of health care products. Its pharmaceutical division directly competes with Health-Chem in multiple therapeutic areas.
Merck &
MRK
Mkt Cap318.55B
Merck operates in the pharmaceutical industry, focusing on innovative therapies and vaccines, which puts it in direct competition with Health-Chem's product lines.
Abbvie
ABBV
Mkt Cap304.29B
AbbVie, with its significant presence in the biopharmaceutical sector, competes with Health-Chem, especially in areas like immunology and oncology.
GSK
GSK
Mkt Cap81.55B
GlaxoSmithKline, a global healthcare company, competes with Health-Chem in the development and distribution of vaccines, prescription medicines, and health-related consumer products.
Novartis
NVS
Mkt Cap232.42B
Novartis is a multinational pharmaceutical company that competes with Health-Chem in researching, developing, manufacturing, and marketing a wide range of healthcare products.
Sanofi
SNY
Mkt Cap128.21B
Sanofi operates globally in the pharmaceutical sector, competing with Health-Chem in areas such as diabetes solutions, human vaccines, and innovative drugs.
Bristol-Myers Squibb
BMY
Mkt Cap86.44B
Bristol Myers Squibb is a global biopharmaceutical company that competes with Health-Chem in the discovery, development, and delivery of innovative medicines.
AMGEN
AMGN
Mkt Cap177.72B
Amgen, a biotechnology company, competes with Health-Chem by focusing on human therapeutics, including treatments for illnesses in areas like oncology and cardiology.
Roche
RHHBY
Mkt Cap220.72B
Roche Holding AG, with its strong emphasis on pharmaceuticals and diagnostics, competes with Health-Chem in the development and marketing of medical solutions and treatments.

About

Textiles
Process Industries
Health-Chem Corporation, through its subsidiary, Transderm Laboratories Corporation, engages in the research, development, manufacture, and marketing of transdermal drug delivery systems in the United States. It offers transdermal nitroglycerin patches used for transdermal relief of the vascular and cardiovascular symptoms related to angina pectoris (chest pain). The company also conducts research and development activities for third parties on a contract basis. Health-Chem Corporation markets its products directly to wholesalers, distributors, retail pharmacy chains, mail order pharmacies, and group purchasing organizations, as well as indirectly to independent pharmacies, managed care organizations, hospitals, nursing homes, and pharmacy benefit management companies. The company was founded in 1970 and is based in Emigsville, Pennsylvania.
Show more...
CEO
Employees
55
Country
US
ISIN
US4221741022

Listings